1. Lipoprotein Profiles before Heparin Administration in Patients with or without Coronary Thrombosis Following Atherosclerosis
- Author
-
Toshihiro Muramatsu, Nobuyuki Komiyama, Katsuyuki Nakajima, Hideaki Kaneda, Ikuo Inoue, and Tomomi Koizumi
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,heparin ,Coronary artery disease ,Coronary thrombosis ,Internal medicine ,medicine ,Myocardial infarction ,cardiovascular diseases ,Risk factor ,thrombosis ,business.industry ,lipoprotein ,Percutaneous coronary intervention ,General Medicine ,Heparin ,medicine.disease ,Thrombosis ,surgical procedures, operative ,Cardiology ,lipids (amino acids, peptides, and proteins) ,Original Article ,business ,coronary artery disease ,medicine.drug ,Lipoprotein ,polyacrylamide gel electrophoresis - Abstract
Objective: The correlation between lipoproteins and arterial thrombosis is not fully elucidated, and no data exist in terms of lipoprotein profiles before heparin administration in patients with coronary arterial thrombosis (CAT). This cross-sectional study aimed to evaluate the lipoprotein profile before heparin administration in 63 ST-segment elevation myocardial infarction (STEMI) patients with CAT. Methods: The lipoprotein profile was measured via polyacrylamide gel electrophoresis prior to heparin administration for primary percutaneous coronary intervention for STEMI. Age- and sex-matched subjects with
- Published
- 2021